Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study.
Moretto R, Rossini D, Catteau A, Antoniotti C, Giordano M, Boccaccino A, Ugolini C, Proietti A, Conca V, Kassambara A, Pietrantonio F, Salvatore L, Lonardi S, Tamberi S, Tamburini E, Poma AM, Fieschi J, Fontanini G, Masi G, Galon J, Cremolini C.
Moretto R, et al. Among authors: giordano m.
J Immunother Cancer. 2023 Apr;11(4):e006633. doi: 10.1136/jitc-2022-006633.
J Immunother Cancer. 2023.
PMID: 37085190
Free PMC article.